Owners, management and financials
CVR: 38238213
Previous names: Perfusion Tech IVS
DKK -6,142,804
Gross profit
Net result: DKK -12,724,708
Renew Pharmaceuticals Limited (100%)
CVR · view owners
Declan Cassells
Board: 1 member
CVR · view management
Active
Founded 28 November 2016
CVR · view overview
6 employees
CVR · 2026
Director role ended: Pernille Charlotte Singer
CVR · 29/09/2025
View the full event history
Perfusion Tech ApS is a Danish company of the type Anpartsselskab based in København Ø, founded in 2016. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named Perfusion Tech IVS. The management consists of Declan Cassells. The board consists of Declan Cassells. The company is owned by Renew Pharmaceuticals Limited. The company has 6 employees (2026). In 2025, the company reported a gross profit of DKK -6,142,804 and a net result of DKK -12,724,708 compared with DKK -14,469,520 the year before. Equity in the 2025 report amounted to DKK -9,640,655.
Selskabet har til formål at udvikle, markedsføre og kommercialisere medicinsk udstyr, herunder ved gennemførelse af forsknings- og udviklingsaktiviteter, og andre hermed relaterede aktiviteter.
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | -6.1 mio. | -12.7 mio. | 4.6 mio. | -9.6 mio. | 11 | |
| 202401/01/2024 – 31/12/2024 | -9 mio. | -14.5 mio. | 5.6 mio. | 2.1 mio. | 11 | |
| 202301/01/2023 – 31/12/2023 | -5.4 mio. | -9.5 mio. | 8.8 mio. | 2.9 mio. | 8 | |
| 202201/01/2022 – 31/12/2022 | -4.2 mio. | -6.6 mio. | 4.9 mio. | 1.2 mio. | 7 | |
| 202101/01/2021 – 31/12/2021 | -1.1 mio. | -2.1 mio. | 1.3 mio. | -3.9 mio. | 4 | |
| 202001/01/2020 – 31/12/2020 | -1.1 mio. | -1.5 mio. | 686 t. | -1.8 mio. | 3 | |
| 201901/01/2019 – 31/12/2019 | -539 t. | -596 t. | 622 t. | -329 t. | 1 | |
| 201801/01/2018 – 31/12/2018 | -262 t. | -238 t. | 471 t. | -453 t. | - | |
| 201728/11/2016 – 31/12/2017 | -278 t. | -272 t. | 311 t. | -214 t. | - |
Compared to 1.039 companies in Forskning og eksperimentel udvikling inden for naturvidenskab og teknik
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
Every Danish company, financial statement and ownership record, straight into your own systems or your AI assistant via MCP.
See the API documentationThe CVR number of Perfusion Tech ApS is 38238213.
Perfusion Tech ApS is owned by Renew Pharmaceuticals Limited.
The management of Perfusion Tech ApS consists of Declan Cassells.
The board of Perfusion Tech ApS consists of Declan Cassells.
In 2025, Perfusion Tech ApS reported a gross profit of DKK -6,142,804.
Perfusion Tech ApS had 6 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Perfusion Tech ApS has published its annual report for 2025. Gross profit came to DKK -6,142,804, and the net result was DKK -12,724,708.
Contact info changed: new email: [email protected], new website: perfusiontech.com (January 22, 2026).
As of September 29, 2025, Declan Cassells is registered as director of Perfusion Tech ApS.
As of September 29, 2025, Pernille Charlotte Singer has stepped down as adm. dir. of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2024. Gross profit came to DKK -9,021,930, and the net result was DKK -14,469,520.
As of June 4, 2025, Jeppe Øvli Øvlesen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, Henrik Christensen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, Thomas Engelbrecht Nordkild Jonassen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, Mads Aagaard Linde Madsen has left the board of directors of Perfusion Tech ApS.
As of June 4, 2025, is registered as an owner of Perfusion Tech ApS with an ownership share of 100%.
As of April 22, 2025, Sten Scheibye has left the board of directors of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2023. Gross profit came to DKK -5,414,376, and the net result was DKK -9,544,785.
As of March 13, 2024, Mads Aagaard Linde Madsen has joined the board of directors of Perfusion Tech ApS.
As of March 13, 2024, Morten Asp Vonsild Lund has left the board of directors of Perfusion Tech ApS.
As of October 1, 2023, Pernille Charlotte Singer is registered as adm. dir. of Perfusion Tech ApS.
As of October 1, 2023, Mads Aagaard Linde Madsen has stepped down as adm. dir. of Perfusion Tech ApS.
As of September 30, 2023, Pernille Charlotte Singer has stepped down as director of Perfusion Tech ApS.
As of September 22, 2023, Henrik Christensen has joined the board of directors of Perfusion Tech ApS.
As of September 22, 2023, Morten Asp Vonsild Lund has joined the board of directors of Perfusion Tech ApS.
As of September 22, 2023, Declan Cassells has joined the board of directors of Perfusion Tech ApS.
As of September 22, 2023, Lars Henning Stigel has left the board of directors of Perfusion Tech ApS.
As of September 21, 2023, Henrik Christensen has left the board of directors of Perfusion Tech ApS.
As of September 21, 2023, Morten Asp Vonsild Lund has left the board of directors of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2022. Gross profit came to DKK -4,201,186, and the net result was DKK -6,556,178.
As of October 24, 2022, Sten Scheibye has joined the board of directors of Perfusion Tech ApS.
As of October 24, 2022, Mads Aagaard Linde Madsen has left the board of directors of Perfusion Tech ApS.
As of October 1, 2022, Pernille Charlotte Singer is registered as director of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2021. Gross profit came to DKK -1,066,804, and the net result was DKK -2,117,687.
As of March 21, 2022, Henrik Christensen has joined the board of directors of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2020. Gross profit came to DKK -1,092,073, and the net result was DKK -1,485,658.
As of December 8, 2020, Lars Henning Stigel has joined the board of directors of Perfusion Tech ApS.
As of December 8, 2020, Steffen Boutrup Møller has left the board of directors of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2019. Gross profit came to DKK -538,894, and the net result was DKK -596,373.
As of November 14, 2019, EY Godkendt Revisionspartnerselskab has been appointed auditor of Perfusion Tech ApS.
As of November 14, 2019, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Perfusion Tech ApS.
Perfusion Tech ApS has published its annual report for 2018. Gross profit came to DKK -261,728, and the net result was DKK -238,245.
Perfusion Tech ApS has published its annual report for 2017. Gross profit came to DKK -278,036, and the net result was DKK -271,716.
As of October 25, 2017, PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Perfusion Tech ApS.
As of October 25, 2017, Jeppe Øvli Øvlesen has joined the board of directors of Perfusion Tech ApS.
As of October 25, 2017, Steffen Boutrup Møller has joined the board of directors of Perfusion Tech ApS.
As of October 25, 2017, Thomas Engelbrecht Nordkild Jonassen has joined the board of directors of Perfusion Tech ApS.
As of October 25, 2017, Morten Asp Vonsild Lund has joined the board of directors of Perfusion Tech ApS.
As of October 25, 2017, Mads Aagaard Linde Madsen has joined the board of directors of Perfusion Tech ApS.
On October 25, 2017, the company changed its name from Perfusion Tech IVS to Perfusion Tech ApS.
As of November 28, 2016, Mads Aagaard Linde Madsen is registered as adm. dir. of Perfusion Tech ApS.
Perfusion Tech ApS was founded on November 28, 2016.
Uneven Bits ApS is an independent IT consultancy founded and operated by Klaus Byskov Pedersen. With deep expertise in software architecture and systems design, I help organizations build robust, scalable, and maintainable technical solutions. Whether you need strategic guidance on technology decisions, hands-on architecture work, or help navigating complex technical challenges, I bring focused expertise and a practical approach to every engagement.
Selskabets formål er at udøve virksomhed med handel og service samt aktiviteter i tilknytning hertil.
Selskabets formål er IT- og kommunikationsvirksomhed samt virksomhed i øvrigt, der efter bestyrelsens skøn står i forbindelse hermed.
Selskabets formål er at udvikle, markedsføre, sælge og implementere software produkter til brug ved indkøbsstyring og dermed efter bestyrelsens skøn beslægtet virksomhed
Companies in the same industry and area
CVR 40172076
CVR 44346206
CVR 41366044
CVR 45436497
CVR 44695065
